Emily M. Leproust
2017
In 2017, Emily M. Leproust earned a total compensation of $2M as President and Chief Executive Officer at Twist Bioscience Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $87,150 |
|---|---|
| Option Awards | $1,587,724 |
| Salary | $340,001 |
| Total | $2,014,875 |
Leproust received $1.6M in option awards, accounting for 79% of the total pay in 2017.
Leproust also received $87.2K in non-equity incentive plan and $340K in salary.
Rankings
In 2017, Emily M. Leproust's compensation ranked 5,470th out of 14,666 executives tracked by ExecPay. In other words, Leproust earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,470 out of 14,666 | 63rd |
Division Manufacturing | 1,967 out of 5,768 | 66th |
Major group Chemicals And Allied Products | 591 out of 2,074 | 72nd |
Industry group Drugs | 453 out of 1,730 | 74th |
Industry Biological Products, Except Diagnostic Substances | 83 out of 316 | 74th |
Source: SEC filing on June 14, 2019.
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019